Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture

Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives

(2018) Joana Mesquita et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Plasma Kallikrein Inhibitors for the Treatment of Retinal Vascular Permeability Associated with Diabetic Retinopathy and Diabetic Macular Edema

(2017) Ahmed F. Abdel-Magid   ACS Medicinal Chemistry Letters

Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010

(2016) Janet L. Leasher et al.   DIABETES CARE

Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment

(2016) E Al Kahtani et al.   EYE

Epigallocatechin-3-gallate protects retinal vascular endothelial cells from high glucose stress in vitro via the MAPK/ERK-VEGF pathway

(2016) L. Zhang et al.   GENETICS AND MOLECULAR RESEARCH

Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy

(2016) Margarida Capitão et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis

(2016) Lingyu Zhou et al.   JOURNAL OF ETHNOPHARMACOLOGY

Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK

(2015) Jing Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1α-VEGF Pathway Inhibition

(2014) Hu Huang et al.   DIABETES

Phenotypes and biomarkers of diabetic retinopathy

(2014) José Cunha-Vaz et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Aqueous humour levels of placental growth factor in diabetic retinopathy

(2013) Ryo Ando et al.   ACTA OPHTHALMOLOGICA

VEGF but not PlGF disturbs the barrier of retinal endothelial cells

(2013) Heidrun L. Deissler et al.   EXPERIMENTAL EYE RESEARCH

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF

(2012) X. Chen et al.   DIABETES OBESITY & METABOLISM

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment

(2012) Gemma Tremolada et al.   Experimental Diabetes Research

Diabetic Retinopathy

(2012) David A. Antonetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy

(2010) KocaboraM Selim et al.   INDIAN JOURNAL OF OPHTHALMOLOGY

STAT1, STAT3 and p38MAPK are involved in the apoptotic effect induced by a chimeric cyclic interferon-α2b peptide

(2009) Viviana C. Blank et al.   EXPERIMENTAL CELL RESEARCH

VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis

(2009) F. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis

(2008) Takaaki Fujii et al.   ATHEROSCLEROSIS

Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas

(2008) X. Zhang et al.   DIABETES

The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes

(2007) Vadim Tchaikovski et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY